Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension
Open Access
- 25 March 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
Abstract
Pulmonary hypertension (PH) is recognized to be associated with a number of comorbid conditions. Based on these associations, PH is classified into 5 groups, considering common pathophysiologic drivers of disease, histopathologic features, clinical manifestations and course, and response to PH therapy. However, in some of these associated conditions, these characteristics are less well-understood. These include, among others, conditions commonly encountered in clinical practice such as sarcoidosis, sickle cell disease, myeloproliferative disorders, and chronic kidney disease/end stage renal disease. PH in these contexts presents a significant challenge to clinicians with respect to disease management. The most recent updated clinical classification schemata from the 6th World Symposium on PH classifies such entities in Group 5, highlighting the often unclear and/or multifactorial nature of PH. An in-depth review of the state of the science of Group 5 PH with respect to epidemiology, pathogenesis, and management is provided. Where applicable, future directions with respect to research needed to enhance understanding of the clinical course of these entities is also discussed.This publication has 206 references indexed in Scilit:
- Extracellular hemin crisis triggers acute chest syndrome in sickle miceJCI Insight, 2013
- Mortality in Adults With Sickle Cell Disease and Pulmonary HypertensionJAMA, 2012
- Pulmonary langerhans cell histiocytosisOrphanet Journal of Rare Diseases, 2012
- Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network reportBlood, 2011
- Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacityBlood, 2011
- Cigarette smoke promotes dendritic cell accumulation in COPD; a Lung Tissue Research Consortium studyRespiratory Research, 2010
- Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studiesBritish Journal of Haematology, 2010
- Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and deathBritish Journal of Haematology, 2009
- Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients With Sickle Cell DiseaseJournal of Invasive Cardiology, 2007
- Elevated Pulmonary Artery Pressure by Doppler Echocardiography Predicts Hospitalization for Heart Failure and Mortality in Ambulatory Stable Coronary Artery Disease: The Heart and Soul StudyJournal of Invasive Cardiology, 2007